Document is current
Any future updates will be listed below
-
Authors
Komé, Anne M. https://orcid.org/0009-0009-7562-3943
Yang, Anita https://orcid.org/0000-0002-7362-205X
Gee, Patrick
Klein, Klara R. https://orcid.org/0000-0002-5894-9054
-
Funding
Funding for this research was provided by:
Bayer Corporation
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 7 February 2025
First Online: 4 March 2025
Declarations
:
: Patrick Gee has received honoraria from FOUNTAIN EAC (Bayer International) Boehringer-Ingelheim and Evidation Health ProKidney Patient Advisory Board. Patrick is also a patient representative on the FOUNTAIN Executive Advisory Committee and ASN Diabetes Kidney Disease-Collaborative Task Force. Anita Yang has no conflicts of interest to disclose. Klara Klein has received consulting fees from Novo Nordisk and has received research-related contracts (paid to the institution) from Bayer, Boehringer-Ingelheim, Carmot, Diasome, Eli Lilly, Novo Nordisk, Rhythm Pharmaceuticals, and vTv Therapeutics. Anne M. Komé has received consulting fees from Camurus, Dexcom, and Lexicomp—Wolters Kluwer.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
